Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeObject Symbol | Species | Term | Qualifier | Evidence | With | Notes | Source | Original Reference(s) | DA.F344-Dpp4DPPIV/SvH | Rat | decreased anxiety-related response | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased anxiety-related response | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased anxiety-related response | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating adrenocorticotropin level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating adrenocorticotropin level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating adrenocorticotropin level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating alanine transaminase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating alanine transaminase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating alanine transaminase level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating alkaline phosphatase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating alkaline phosphatase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating alkaline phosphatase level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating aspartate transaminase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating aspartate transaminase level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating aspartate transaminase level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating corticosterone level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating corticosterone level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating corticosterone level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating interleukin-6 level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating interleukin-6 level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating interleukin-6 level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased circulating triglyceride level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased circulating triglyceride level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased circulating triglyceride level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased eosinophil cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased eosinophil cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased eosinophil cell number | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased interleukin-6 secretion | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased interleukin-6 secretion | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased interleukin-6 secretion | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased lymphocyte cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased lymphocyte cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased lymphocyte cell number | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased response to stress-induced hyperthermia | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased response to stress-induced hyperthermia | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased response to stress-induced hyperthermia | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased susceptibility to diet-induced obesity | induced | IAGP | controlled calorie content diet | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased susceptibility to diet-induced obesity | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased susceptibility to diet-induced obesity | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | decreased susceptibility to weight gain | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | decreased susceptibility to weight gain | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | decreased susceptibility to weight gain | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | impaired natural killer cell mediated cytotoxicity | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | impaired natural killer cell mediated cytotoxicity | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | impaired natural killer cell mediated cytotoxicity | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | improved glucose tolerance | induced | IAGP | glucose solution | compared to DA/Ztm | RGD | | Dpp4 | Rat | improved glucose tolerance | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | improved glucose tolerance | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased B-1 B cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased B-1 B cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased B-1 B cell number | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased blood urea nitrogen level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased blood urea nitrogen level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased blood urea nitrogen level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased circulating glucagon level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased circulating glucagon level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased circulating glucagon level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased circulating phosphate level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased circulating phosphate level | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased circulating phosphate level | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased exploration in new environment | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased exploration in new environment | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased exploration in new environment | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | increased NK cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4 | Rat | increased NK cell number | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | increased NK cell number | | IAGP | | compared to DA/Ztm | RGD | | DA.F344-Dpp4DPPIV/SvH | Rat | weight loss | induced | IAGP | controlled gliadin content diet | compared to DA/Ztm | RGD | | Dpp4 | Rat | weight loss | | IAGP | | compared to DA/Ztm | RGD | | Dpp4DPPIV | Rat | weight loss | | IAGP | | compared to DA/Ztm | RGD | | |